, Percentage variation (right panels) or absolute value (left panels) for spleen uptake between baseline and interim PET, depending on the metabolic active tumour volume (MATV) on baseline scan (a), the type of G-CSF (b) and the time-lapse between the last injection of chemotherapy and the PET examination (c), Figure, vol.5

G. J. Lieschke and A. W. Burgess, Granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor (1), vol.327, pp.28-35, 1992.

G. J. Lieschke and A. W. Burgess, Granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor (2), vol.327, pp.99-106, 1992.

H. A. Jacene, T. Ishimori, J. M. Engles, S. Leboulleux, V. Stearns et al., Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies, Society of Nuclear Medicine, vol.47, pp.950-956, 2006.

Y. Sugawara, K. R. Zasadny, P. V. Kison, L. H. Baker, and R. L. Wahl, Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results, Society of Nuclear Medicine, vol.40, pp.1456-62, 1999.

R. Boellaard, R. Delgado-bolton, W. J. Oyen, F. Giammarile, K. Tatsch et al., FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. European journal of nuclear medicine and molecular imaging, vol.42, pp.328-54, 2015.

R. Boellaard, M. J. O'doherty, W. A. Weber, F. M. Mottaghy, M. N. Lonsdale et al.,

F. Pet and P. Ct, EANM procedure guidelines for tumour PET imaging: version 1.0. European journal of nuclear medicine and molecular imaging, vol.37, pp.181-200, 2010.

M. E. Juweid, S. Stroobants, O. S. Hoekstra, F. M. Mottaghy, M. Dietlein et al., Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma, J Clin Oncol, vol.25, pp.571-579, 2007.

S. F. Barrington and R. Kluge, FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. European journal of nuclear medicine and molecular imaging, vol.44, pp.97-110, 2017.

J. M. Beauregard, M. S. Hofman, G. Kong, and R. J. Hicks, The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapy. European journal of nuclear medicine and molecular imaging, vol.39, pp.50-56, 2012.

N. Aide, C. Lasnon, P. Veit-haibach, T. Sera, B. Sattler et al., EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. European journal of nuclear medicine and molecular imaging, vol.44, pp.17-31, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01856095

C. Lasnon, T. Salomon, C. Desmonts, P. Do, Y. Oulkhouir et al., Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARLcompliant reconstruction, Ann Nucl Med, vol.31, pp.125-159, 2017.

T. Salomon, C. Nganoa, A. C. Gac, C. Fruchart, G. Damaj et al., Assessment of alteration in liver (18)F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score, European journal of nuclear medicine and molecular imaging, vol.45, pp.941-50, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01856020

W. C. Tsoi, K. F. To, and C. S. Feng, Splenic hematopoiesis after granulocyte-colony stimulating factor therapy in a lupus patient, American journal of hematology, vol.53, pp.283-287, 1996.

X. Wu, A. Bhattarai, P. Korkola, H. Pertovaara, H. Eskola et al., The Association Between Liver and Tumor [18F]FDG Uptake in Patients with Diffuse Large B Cell Lymphoma During Chemotherapy. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2017.

B. K. Teo, S. Badiee, M. Hadi, T. Lam, L. Johnson et al., Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies. Nuclear medicine communications, vol.29, pp.359-66, 2008.